Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (41-50 of 652) with videos related to

Pageof 66
Sort By:
Kardiologia Polska|December 18, 2025
Time for change: Awaiting the 2025 Impact FactorAnetta Undas
Kardiologia Polska|July 13, 2016
Who could benefit most from treatment of acute pulmonary embolism with rivaroxaban? Commentary to the article: "Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy…Anetta Undas
Biomed Research International|July 26, 2017
Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for RecurrenceAnetta Undas
Polish Archives of Internal Medicine|June 24, 2025
The latest impact factor of Polish Archives of Internal Medicine is a huge success of Polish clinical scienceAnetta Undas
Seminars in Thrombosis and Hemostasis|April 20, 2021
Fibrinolysis in Venous ThromboembolismAnetta Undas
Kardiologia Polska|July 3, 2026
Polish Heart Journal improves its standing: a record Impact Factor of 4.4Anetta Undas
Kardiologia Polska|February 6, 2018
EditorialAnetta Undas
Kardiologia Polska|September 8, 2021
The highest Impact Factor of Kardiologia Polska announced in June 2021: we did it!Anetta Undas
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 19, 2019
Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implicationsAnetta Undas
Polish Archives of Internal Medicine|February 28, 2022
10th death anniversary of Professor Andrzej Szczeklik: his impact on Pol Arch Intern Med (Pol Arch Med Wewn) and beyondAnetta Undas
Pageof 66

Showing results (41-50 of 652) with videos related to

Sort By:
Pageof 66
Kardiologia Polska|December 18, 2025
Time for change: Awaiting the 2025 Impact FactorAnetta Undas
Kardiologia Polska|July 13, 2016
Who could benefit most from treatment of acute pulmonary embolism with rivaroxaban? Commentary to the article: "Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy…Anetta Undas
Biomed Research International|July 26, 2017
Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for RecurrenceAnetta Undas
Polish Archives of Internal Medicine|June 24, 2025
The latest impact factor of Polish Archives of Internal Medicine is a huge success of Polish clinical scienceAnetta Undas
Seminars in Thrombosis and Hemostasis|April 20, 2021
Fibrinolysis in Venous ThromboembolismAnetta Undas
Kardiologia Polska|July 3, 2026
Polish Heart Journal improves its standing: a record Impact Factor of 4.4Anetta Undas
Kardiologia Polska|February 6, 2018
EditorialAnetta Undas
Kardiologia Polska|September 8, 2021
The highest Impact Factor of Kardiologia Polska announced in June 2021: we did it!Anetta Undas
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 19, 2019
Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implicationsAnetta Undas
Polish Archives of Internal Medicine|February 28, 2022
10th death anniversary of Professor Andrzej Szczeklik: his impact on Pol Arch Intern Med (Pol Arch Med Wewn) and beyondAnetta Undas
Pageof 66